CAS: 871026-44-7 - TAK 285
Formula:C26H25ClF3N5O3
- Synonyms:
- N-[2-[4-[[3-Chloro-4-[3-(trifluoromethyl)phenoxy]phenyl]amino]-5H-pyrrolo[3,2-d]pyrimidin-5-yl]ethyl]-3-hydroxy-3-methylbutanamide
- TAK-285
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | TAK-285 REF: IN-DA00GU6MCAS: 871026-44-7 | % | 61.00 €~309.00 € | Tue 07 Jan 25 |
 | TAK-285 REF: 7W-GW3736CAS: 871026-44-7 | - - - | 418.00 €~1,057.00 € | Tue 14 Jan 25 |
 | TAK-285 REF: TM-T6039CAS: 871026-44-7 | 99.17% | 40.00 €~551.00 € | Tue 11 Feb 25 |
 | TAK 285 REF: 3D-FT103851CAS: 871026-44-7 | Min. 95% | To inquire | Tue 18 Feb 25 |
Ref: 7W-GW3736
| 1mg | 418.00 € | ||
| 5mg | 643.00 € | ||
| 10mg | 1,057.00 € |
Estimated delivery in United States, on Tuesday 14 Jan 2025
TAK-285
CAS:871026-44-7
TAK-285 is a novel dual HER2 and EGFR(HER1) inhibitor, >10-fold selectivity for HER1/2 than HER4, …
Formula:
C26H25ClF3N5O3
Purity:
99.17%
Color and Shape:
Solid
Molecular weight:
547.96
Ref: TM-T6039
| 1mg | 40.00 € | ||
| 5mg | 85.00 € | ||
| 10mg | 122.00 € | ||
| 25mg | 227.00 € | ||
| 50mg | 371.00 € | ||
| 100mg | 551.00 € | ||
| 1mL*10mM (DMSO) | 94.00 € |
Estimated delivery in United States, on Tuesday 11 Feb 2025
TAK 285
CAS:871026-44-7
Inhibitor of HER2/EGFR receptor
Formula:
C26H25ClF3N5O3
Purity:
Min. 95%
Molecular weight:
547.96 g/mol
Ref: 3D-FT103851
| 10mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Tuesday 18 Feb 2025
